COMMUNIQUÉS West-GlobeNewswire

Pure Radiance Medispa Introduces Seattle’s First FDA-Cleared, Needle-Free Hair Growth Laser With Zero Downtime
05/01/2026
Non-surgical hormone-safe solution now available for patients seeking stronger, fuller, natural hair growth. Seattle, WA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Pure Radiance Medispa , one of Seattle’s leading destinations [...]
Natural Weight Loss Florida Launches Habit-Based Support Program for Clients Using Weight-Loss Medications
05/01/2026
Innovative Service Aims to Build Sustainable Habits Alongside Medication Use Boca Raton, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- As weight-loss medications such as GLP-1 therapies become increasingly common, many [...]
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
05/01/2026
-Coherus Oncology formally introduces non-proprietary name: tagmokitug- -Publication shows picomolar affinity for CCR8 with no off-target binding and proof-of- mechanism in preclinical and clinical studies- -Data show [...]
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
05/01/2026
CHICAGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) ( NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its wholly owned [...]
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
05/01/2026
Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next [...]
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
05/01/2026
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]
Mainz Biomed Provides Review of 2025 Highlights
05/01/2026
Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population in Preparation for ReconAAsense U.S. FDA Pivotal Trial Results from [...]
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
05/01/2026
Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today [...]
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
05/01/2026
- Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and feedback from the [...]
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
05/01/2026
Taipei, Taiwan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications
05/01/2026
MIAMI, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, today announced that it has engaged Hayden IR, a nationally recognized investor [...]
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
Tokyo, Japan and Cambridge, UK, 5 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that Chris Cargill, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare [...]
Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®
05/01/2026
MANKATO, Minn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES), the manufacturer of Terreplenish®, a leading organic microbial soil-replenishing technology, today announced a new [...]
PolarityBio Announces AMA Publication of New Category III CPT Codes for SkinTE® Procedures
05/01/2026
New procedural codes establish standardized pathway for clinical use of autologous heterogeneous skin construct across care settings SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- PolarityBio© , a clinical-stage [...]
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
05/01/2026
January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical [...]
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
VANCOUVER, British Columbia and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44 th Annual J.P. Morgan Healthcare Conference and provide a [...]
rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities
05/01/2026
FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor consulting and health services company, today issued a letter to its shareholders [...]

Pages